ZYDELIG (idelalisib) tablets

ZYDELIG is a brand-name prescription drug that’s FDA-approved to treat chronic lymphocytic leukemia (CLL), Relapsed follicular B-cell non-Hodgkin lymphoma, Relapsed small lymphocytic lymphoma (SLL). Brand Name: ZYDELIG (idelalisib) tablets, for oral use Initial U.S. Approval: 2014

Home | idelalisib tablets

ZYDELIG (idelalisib) tablets price in India and Overseas
ZYDELIG (idelalisib) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ZYDELIG (idelalisib) tablets

Idelalisib is indicated for the treatment of chronic lymphocytic leukemia (CLL), Relapsed follicular B-cell non-Hodgkin lymphoma, Relapsed small lymphocytic lymphoma (SLL).

Zydelig is a kinase inhibitor indicated for the treatment of patients with:
• Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.
• Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.
• Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies

Idelalisib is approved to treat: Chronic lymphocytic leukemia (CLL) that has relapsed (come back). It is used with rituximab in patients who may be treated with rituximab alone due to other health problems. Idelalisib is also being studied in the treatment of other types of cancer.

Drug (Brand / Generic): ZYDELIG / idelalisib
Current Indications: chronic lymphocytic leukemia
Marketed by:: Gilead Sciences, Inc.
Approval Date:2014

Available as (Form & Strength): Tablets: 150 mg, 100 mg.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.